Professor Christopher Pepper



Prosiectau fel Prif Ymchwiliwr
null null 1 o 3 null null

Developing novel agents for targeting multiple myeloma - Cyllidwr:Leukaemia Research Appeal for Wales (01.10.2013 - 30.09.2016)
Novel NF-kB transcription factor inhibitors for the treatment of haematological cancers - Cyllidwr:Worldwide Cancer Research (01.10.2013 - 30.06.2016)
A phase II trial of cyclosporine A in early adverse risk CLL (CyCLL) - Cyllidwr:Blood Cancer UK (01.10.2013 - 30.09.2015)
BTK inhibition in the dynamic circulating system - Cyllidwr:Ono Pharmaceuticals Laboratories Co Ltd (01.11.2013 - 31.10.2016)


Prosiectau fel Cyd-Ymchwiliwr
null null 1 o 4 null null

The role of tumour specific T cell in CLL - Cyllidwr:Blood Cancer UK (11.08.2014 - 31.08.2017)
Telomere dynamics and dysfunction in CLL - Cyllidwr:Blood Cancer UK (01.09.2011 - 12.11.2014)
Breaking T cell tolerance in chronic lymphocytic leukaemia - Cyllidwr:Cancer Research Wales (01.02.2010 - 01.02.2013)

Diweddarwyd y tro diwethaf ar 2020-25-10 am 05:01